Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

W. Lam; A. Nowak; F. Chen; S. Muruganandan; S. Arunachalam; M. Chin; M. Millward; C. Read; K. Murray; J. Creaney; Y. C. G. Lee

doi:10.1016/j.jtho.2019.08.691

Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

W. Lam
, A. Nowak
, F. Chen
, S. Muruganandan
, S. Arunachalam
, M. Chin
, M. Millward
, C. Read
, K. Murray
, J. Creaney
, Y. C. G. Lee

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	S342-S342
Number of pages	1
Journal	Journal of Thoracic Oncology
Volume	14
Issue number	10
DOIs	https://doi.org/10.1016/j.jtho.2019.08.691
Publication status	Published - Oct 2019

Access to Document

10.1016/j.jtho.2019.08.691

Cite this

Lam, W., Nowak, A., Chen, F., Muruganandan, S., Arunachalam, S., Chin, M., Millward, M., Read, C., Murray, K., Creaney, J., & Lee, Y. C. G. (2019). Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study. Journal of Thoracic Oncology, 14(10), S342-S342. https://doi.org/10.1016/j.jtho.2019.08.691

@article{5a9330515814459384fc45c235f8a5f7,

title = "Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study",

keywords = "FGF, AZD4547, Mesothelioma",

author = "W. Lam and A. Nowak and F. Chen and S. Muruganandan and S. Arunachalam and M. Chin and M. Millward and C. Read and K. Murray and J. Creaney and Lee, \{Y. C. G.\}",

year = "2019",

month = oct,

doi = "10.1016/j.jtho.2019.08.691",

language = "English",

volume = "14",

pages = "S342--S342",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "10",

}

Lam, W, Nowak, A , Chen, F, Muruganandan, S, Arunachalam, S, Chin, M, Millward, M , Read, C , Murray, K , Creaney, J & Lee, YCG 2019, 'Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study', Journal of Thoracic Oncology, vol. 14, no. 10, pp. S342-S342. https://doi.org/10.1016/j.jtho.2019.08.691

TY - JOUR

T1 - Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma

T2 - Final Results of FRAME Study

AU - Lam, W.

AU - Nowak, A.

AU - Chen, F.

AU - Muruganandan, S.

AU - Arunachalam, S.

AU - Chin, M.

AU - Millward, M.

AU - Read, C.

AU - Murray, K.

AU - Creaney, J.

AU - Lee, Y. C. G.

PY - 2019/10

Y1 - 2019/10

KW - FGF

KW - AZD4547

KW - Mesothelioma

U2 - 10.1016/j.jtho.2019.08.691

DO - 10.1016/j.jtho.2019.08.691

M3 - Abstract/Meeting Abstract

SN - 1556-0864

VL - 14

SP - S342-S342

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -